Clinical Trials Browser

Completed × Choriocarcinoma × carotuximab × Clear all

NCT02396511 2019-06-11

TRC105 Combined With Standard-dose Bevacizumab for Two Patients With Metastatic And Refractory Choriocarcinoma

Phase 2 Completed

2 enrolled 10 charts

Choriocarcinoma